Asparagine synthetase is associated with apoptosis inhibition, protein biosynthesis, and mTORC1 activation in non-small cell lung cancer, which inhibits ASNS expression, and, combined with the depletion of extracellular asparagine, can reduce the risk of non-small cell lung cancer growth (21). The gene discussed is ASNS; the disease is non-small cell lung carcinoma.